This content is in French.
Efficacy of sorafenib combined with transcatheter arterial chemoembolisation (TACE) in the treatment of hepatocellular carcinoma with tumour thrombosis of the portal vein: a meta-analysis
9 septembre 2024
Twelve randomised controlled trials published up to 2022 were included. Of a total of 1,746 patients, 458 received sorafenib + TACE (S+TACE arm) and 1,288 underwent TACE (TACE arm).
Sign in to read the rest
Reserved for healthcare professionals, free registration.
